Clinical Trial Update: A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial of aprocitentan for uncontrolled blood pressure in chronic kidney disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Aprocitentan (aprocitentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Hypertension, Renal Insufficiency, Chronic | Phase 3 | Status: WITHDRAWN